Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP618275.RAOHcTm1nVe-kIR3TY3yK5l9rwu3ZSGmsjMPRY-MFHVwg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP618275.RAOHcTm1nVe-kIR3TY3yK5l9rwu3ZSGmsjMPRY-MFHVwg130_assertion type Assertion NP618275.RAOHcTm1nVe-kIR3TY3yK5l9rwu3ZSGmsjMPRY-MFHVwg130_head.
- NP618275.RAOHcTm1nVe-kIR3TY3yK5l9rwu3ZSGmsjMPRY-MFHVwg130_assertion description "[To effectively target dyslipidemia to reduce the risk of cardiovascular disease, it may be beneficial to activate the peroxisome proliferator-activated receptors (PPARs) PPARalpha and PPARdelta simultaneously through a single molecule.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP618275.RAOHcTm1nVe-kIR3TY3yK5l9rwu3ZSGmsjMPRY-MFHVwg130_provenance.
- NP618275.RAOHcTm1nVe-kIR3TY3yK5l9rwu3ZSGmsjMPRY-MFHVwg130_assertion evidence source_evidence_literature NP618275.RAOHcTm1nVe-kIR3TY3yK5l9rwu3ZSGmsjMPRY-MFHVwg130_provenance.
- NP618275.RAOHcTm1nVe-kIR3TY3yK5l9rwu3ZSGmsjMPRY-MFHVwg130_assertion SIO_000772 17608467 NP618275.RAOHcTm1nVe-kIR3TY3yK5l9rwu3ZSGmsjMPRY-MFHVwg130_provenance.
- NP618275.RAOHcTm1nVe-kIR3TY3yK5l9rwu3ZSGmsjMPRY-MFHVwg130_assertion wasDerivedFrom befree-2016 NP618275.RAOHcTm1nVe-kIR3TY3yK5l9rwu3ZSGmsjMPRY-MFHVwg130_provenance.
- NP618275.RAOHcTm1nVe-kIR3TY3yK5l9rwu3ZSGmsjMPRY-MFHVwg130_assertion wasGeneratedBy ECO_0000203 NP618275.RAOHcTm1nVe-kIR3TY3yK5l9rwu3ZSGmsjMPRY-MFHVwg130_provenance.